Evangelos Giampazolias

❗Cross-presentation shapes neoantigen visibility and cancer immunogenicity in #NatureImmunology🤯
www.nature.com/articles/s41...
Huge congratulations @drjonlim.bsky.social 🥂
Inspired and so lucky to have you in #Manchester 🐝
Congratulations to #OliverSchulz, @reisesousalab.bsky.social , @crick.ac.uk

Absolutely delighted that our latest paper is out today @natimmunol.nature.com. It has taken five years to uncover a role for cross-presentation in shaping the immune visibility of tumour antigens. A labour of love led by @drjonlim.bsky.social and Oliver Schulz. Great start of 2026!

Overcoming Barriers to Cell Therapy - From Spatial Immunology to the Scalability Gap - MedScriptum In this interview, Dr. Lim unpacks the evolving role of cell therapies and reveals the gaps between promise and practice that call for fresh thinking.

🎙️ Enjoyed speaking with Salome Chkheidze, a medical student at Tbilisi State Medical University & journalist at Medscriptum, about precision oncology and the evolving opportunities (and challenges! of cell therapy in solid tumours.

Many thanks for the interview feature 👇

🎙️ Great to hear Samra @turajliclab.bsky.social and @manifest-cirrp.bsky.social featured on BBC Radio 5 Live 👇

Major study launched to make advanced cancer treatments safer for patients A major new UK study, led by The Christie NHS Foundation Trust and The University of Manchester, has been launched to help patients with cancer better tolerate cutting-edge immunotherapy treatments li...

Hear more about RISE + why tackling safety/toxicity in advanced therapies is centre to our programme.

We're humbled to hear from Elkie Mellor, who generously shared her lived experience. Voices like hers are a powerful reminder of why this work matters & will continue to motivate everything we do.

Graphic advertising the Immunotherapy Crash Course, with a photograph of Prof Turajlić, a QR code for booking and the details of the event (as in the main text of the message) along with a background image of cells and tissues

Our Institute Director, Professor Samra Turajlić, will be giving a public talk at @crick.ac.uk

💬Crick Crash Course: Immunotherapy
📅Wed 19th Nov
🕙10am
📌Crick Institute, London

For full details and to book: www.eventbrite.co.uk/e/crick-cras...

@turajliclab.bsky.social #Immunotherapy

You've got just a few days left to submit your proposal to join us as a new Group Leader

📅 Applications close 2nd November

Package includes:

🪙Multi-year funding
🧪Core Facility Access
🥼 #Postdoc & #PhD positions
🤝Mentorship

Visit our website to apply:
www.cruk.manchester.ac.uk/career/new-g...

🎓 Fully-funded 4-yr MRC PhD @officialuom.bsky.social!

Join a world-class team exploring how the microenvironment drives CRS in CAR-T therapy.

🌍 Open globally | 💥 Translational science
🗓️ Apply by 8 Nov 2025
🔗 www.findaphd.com/phds/project...

#PhDOpportunity #TeamManchester 🐝
@uom-dcs.bsky.social

We are excited to announce that our #PhD Student Recruitment is open for applications!

For full details of all projects and information on how to apply, visit: www.cruk.manchester.ac.uk/phd-student-...

📅 Applications close 28th November & we look forward to hearing from you!

MI/25/57 Postdoctoral Scientist | Cancer Research UK Manchester Institute A postdoctoral position is available in the laboratory of Sylvain Delaunay to study how diet affects RNA modifications to drive cancer progression.

You have just *4 days* left to apply for a #Postdoc position with the fab @sylvaindelaunay.bsky.social

Study how diet affects #RNA modifications to drive cancer progression with:

🔵In vivo models
🔵Patient samples
🔵Long-read #Nanopore seq
🔵 #CRISPR screens

www.cruk.manchester.ac.uk/career/mi-25...

Group Leader Recruitment at the Cancer Research UK Manchester Institute YouTube video by CRUK Manchester Institute

Exciting news - we are recruiting new Group Leaders! 🥼

We are seeking to appoint exceptional early-career scientists & clinician scientists as #GroupLeaders to develop bold, innovative, high-impact #CancerResearch programmes

Full details on our website: www.cruk.manchester.ac.uk/career/new-g...

Glucocorticoids Unleash Immune-dependent Melanoma Control Through Inhibition Of The GARP/TGF β Axis | Cancer Research UK Manchester Institute This study uncovers a surprising role for GCs in triggering CD8+ T cell–dependent tumour control through downregulation of GARP and thus TGF β signalling.

Exciting new research from our Cancer Inflammation and Immunity Group led by @santiagozelenay.bsky.social on the counterintuitive effects of steroids to enhance responses to immunotherapy in #melanoma

Visit our website for more on this paper published today in Cancer Discovery

Now online in Cancer Discovery @aacrjournals.bsky.social: Glucocorticoids Unleash Immune-dependent Melanoma Control through Inhibition of the GARP/TGF β Axis - by Charles Earnshaw, @santiagozelenay.bsky.social, and colleagues doi.org/10.1158/2159... @cruk-mi.bsky.social

Image shows graphics of calendars and clocks, text reads 3 days to go - time is running out - apply for this role today! MI/25/33_2 Postdoctoral Scientist Systems Oncology Group Apply by 26th October

Just 3 days left to apply for a #postdoc position with @clausjorgensen.bsky.social and the Systems Oncology group

🥼Study a novel therapeutic target in #PancreaticCancer relating to the #TumourMicroenvironment

For full details & to apply please visit: www.cruk.manchester.ac.uk/career/mi-25...

MI/25/33_2 Postdoctoral Scientist | Cancer Research UK Manchester Institute Dr Claus Jorgensen, Group Leader of the Systems Oncology Group, is looking for a Postdoctoral Scientist to join his group. This is a great opportunity for a self-motivated, innovative, meticulous and ...

One great opportunity is for a self-motivated, innovative, meticulous and organised candidate who is keen to work in a dynamic laboratory undertaking cutting edge research with Prof @clausjorgensen.bsky.social as a #PostdoctoralScientist

Full details at:

www.cruk.manchester.ac.uk/career/mi-25...

Best and worst-performing NHS Trusts in England named Critics question the usability of new league tables meant to inform the public and let them exercise choice.

People make places. Proud to be part of #TeamManchester 🐝, and to work alongside inspiring colleagues who consistently go above and beyond - always putting patients first.

🏆 The Christie NHS Foundation Trust
@mcrcnews.bsky.social

www.bbc.co.uk/news/article...

The Past, Present and Future of Immunology Research – with Caetano Reis e Sousa YouTube video by Francis Crick Institute

My "Crash Course in …Immunology" is now posted on YouTube youtu.be/nBC9vvlTxF8. Taken from a public lecture @crick.ac.uk on history and basic concepts in immunity. Aimed at the lay public and those seeking an introductory overview.

Delighted that our paper describing cDC1 states and their distribution in mouse tumours is out today in @eurjimmunol.bsky.social. Many congratulations to Cécile Piot who led this work and brought it to conclusion! onlinelibrary.wiley.com/doi/10.1002/...

Thrilled to welcome #SamraTurajlić to the #ManchesterFamily 🐝!

We are excited for her vision and leadership in driving world-class, multidisciplinary cancer research, and proud to be part of this journey together!

I'm deeply honoured to receive the BACR/AstraZeneca Young Scientist Frank Rose Award in recognition of my cancer research.
Grateful to @thebacr.bsky.social @astra-zeneca.bsky.social ‬ #Mentors & #Colleagues whose support has shaped this journey.

My reflections👇
🔗 www.bacr.org.uk/news/2025-ba...

May is #SunAwarenessMonth prompting thoughts of #SkinCancer & #VitaminD - but there's more! 🧪

Group leader @giampazolias.bsky.social spoke to BBC Science Focus about the relationship between Vitamin D, the gut #microbiome & cancer #immunity

Read the story:
www.cruk.manchester.ac.uk/news/institu...

Announcement image - dark blue background with coloured overlapping circles Top shows the Cancer Research UK Manchester Institute Logo Centre shows a photograph of Professor Samra Turajlić Text says: "A warm welcome to our new Director, Professor Samra Turajlić, from all staff and students at the Cancer Research UK Manchester Institute"

We are delighted to announce, along with Cancer Research UK (@cancerresearchuk.org), The University of Manchester (@manchester.ac.uk) and The Christie NHS Foundation Trust, the appointment of Professor Samra Turajlić as our new Director! ⭐

Full story here: www.cruk.manchester.ac.uk/news/profess...

Thrilled to announce I'm moving to Manchester to lead the Cancer Origins group! If you're interested in how mutations and exposures drive tumourigenesis — come join the adventure

🚀 In the past 6 months or so, we have been busy setting up #MANIFESTuk + getting it up & running 🇬🇧.

Delighted to share an overview of our Consortium's vision & ambitions to drive the future of #CancerImmunotherapy:
aacrjournals.org/cancerdiscov...

@zaydtippu.bsky.social
@manifest-cirrp.bsky.social

Great Lab! Don’t miss the opportunity and apply👇

💡Inspiring to be in amongst esteemed colleagues at BSI Cancer Immunotherapies Summit today at The Royal Society.

Happy to share our vision & ambitions for #MANIFESTuk + how we can work collaboratively to tackle some of the biggest questions in immuno-oncology.

@manifest-cirrp.bsky.social

💥Exciting #Postdoc opportunity in my lab at @cruk-mi.bsky.social to study the role of #RNADynamics in cancer progression!

⏰Deadline: 07/05/25

Apply 👇
www.cruk.manchester.ac.uk/career/mi-24...

⏩ Please share this with your network.

#CancerResearch #RNADynamics #RNAmodification #CRUK #postdoc

⚠️ SAVE THE DATE ⚠️

CFCD meeting - December 4th-5th 2025

Unveiling the future of Dendritic Cell and Macrophage biology in health and disease 🔥🔥🔥

Venue : Institut Curie in Paris

Amazing keynotes by

Yasmine Belkaid (Institut Pasteur)
Dan Litmann (NYU)

Registrations open soon

🚨 Final day to send in your application to join @giampazolias.bsky.social & the Cancer Immunosurveillance group @cruk-mi.bsky.social.

Don’t miss this great opportunity!
@mcrcnews.bsky.social

💥Exciting new #postdoc opportunities in my lab at @cruk-mi.bsky.social i.bsky.social to study #NutrientHostMicrobiome interactions in #CancerImmunity in mice and humans. #CancerImmunology#MucosalImmunology#Microbiome

⏰Deadline: 4 April 2025
Apply👇
www.cruk.manchester.ac.uk/career/mi-24...

⏩RT